Canady Technology

Canady Life Sciences is a clinical-stage biotechnology company specializing in the development of Cold Atmospheric Plasma (CAP) for the treatment of solid tumors. As a subsidiary of US Medical Innovations, the company focuses on "Plasma Oncology," a field that utilizes ionized gas to selectively induce apoptosis in cancer cells while sparing healthy tissue. Their flagship technology, the Canady Helios Cold Plasma System, is currently being evaluated in clinical trials for its ability to eliminate residual microscopic disease at surgical margins. The company integrates advanced electrosurgical engineering with molecular research to provide surgeons with novel tools for intraoperative cancer therapy.